The 19,000 sq ft state-of-the-art facility will be the global manufacturing plant for Evoqua’s Ionpure Continuous Electrodeionization (CEDI) products. Evoqua’s Ionpure brand was the first to commercialize CEDI for water purification, a chemical-free, self-regenerating technology that provides a consistent flow of high-quality deionized water.
The investment supports Evoqua’s efforts to localise production to better serve the increasing demand for ultrapure water solutions in the APAC region, predominately in the microelectronics and pharmaceutical industries.
“The establishment of this new manufacturing facility supports Evoqua’s growth and market development plans for the Asia-Pacific market,” said Ron Keating, Evoqua CEO. “Our expanded presence allows us to meet the growing needs of the APAC market, strengthening our commitment to helping our customers across the region address their critical water treatment needs.”
The new facility is expected to bring approximately 30 jobs to the region.
